Therefore, we applied hydroxychloroquine (HCQ) for inhibiting amino acid metabolism in cisplatin-insensitive neuroblastoma cells based on the premise that HCQ inhibits terminal phase of autophagy, recycling of cellular receptors involved in nutrient uptake, as well as mTOR pathways. The gene discussed is MTOR; the disease is neuroblastoma.